Gariox Pharmaceuticals Private Limited
About Gariox Pharmaceuticals Private Limited
Data last updated:
Gariox Pharmaceuticals Private Limited is a private limited company based in Bhiwandi, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 29 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2020PTC342897.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Julfikar Ali Bhutto and Zahangir Alom.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at H.No. 1000 Salman Nagar Mahapoli Village Wada Rd Bhiwandi, Maharashtra, India – 421302.
As per the financials filed for FY 2022, the company reported a revenue of ₹2.45 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹63,090 (net margin -25.8%) and EBITDA of -₹62,866 (EBITDA margin -25.7%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH.No. 1000 Salman Nagar Mahapoli Village Wada Rd Bhiwandi, Maharashtra, India – 421302
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Gariox Pharmaceuticals Private Limited FY 2022 filings available
Gariox Pharmaceuticals Private Limited reported revenue of ₹2.45 Lakh (up 2347% YoY) for FY 2022.
Financial Statement Summary of Gariox Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹62,866 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹63,090 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Gariox Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -25.7% | •••• |
| Net Profit Margin | -25.8% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Gariox Pharmaceuticals are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Gariox Pharmaceuticals Private Limited
Gariox Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lucenta Pharmaceuticals Private Limited | ₹2.49 Lakh (FY 2020) | •••• | •••• | -76.0% | •••• | Yamuna Nagar, Haryana, India |
| Cemach Pharmaceuticals Private Limited | ₹2.49 Lakh (FY 2019) | •••• | •••• | 77.0% | •••• | Pune, Maharashtra, India |
| Medesign Pharmaceuticals Private Limited | ₹2.49 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | Delhi, India |
| Morbocure Pharmaceuticals Private Limited | ₹2.49 Lakh (FY 2024) | •••• | •••• | -55.0% | •••• | Mathura, Uttar Pradesh, India |
| Qassur Pharmaceuticals Private Limited | ₹2.46 Lakh (FY 2025) | •••• | •••• | •••• | Thrissur, Kerala, India | |
| Gariox Pharmaceuticals Private Limited this company | ₹2.45 Lakh (FY 2022) | •••• | •••• | 2347.0% | •••• | Bhiwandi, Maharashtra, India |
| Albert Pharmaceuticals Private Limited | ₹2.43 Lakh (FY 2021) | •••• | •••• | -49.0% | •••• | Gopalganj, Bihar, India |
| Sorrell Pharmaceuticals Private Limited | ₹2.42 Lakh (FY 2022) | •••• | •••• | 88.0% | •••• | Hyderabad, Telangana, India |
| Calista Pharmaceuticals Private Limited | ₹2.41 Lakh (FY 2022) | •••• | •••• | 20.0% | •••• | Nayagarh, Odisha, India |
| Emblem Pharmaceuticals Private Limited | ₹2.41 Lakh (FY 2025) | •••• | •••• | -58.0% | •••• | Delhi, India |
| Evoluent Pharmaceuticals Private Limited | ₹2.41 Lakh (FY 2021) | •••• | •••• | -55.0% | •••• | Palace Guttahalli, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Gariox Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Gariox Pharmaceuticals Private Limited
Gariox Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aktara Begum | Additional Director | 08 Jun 2022 | 4 Years 4 Months | Current |
| Julfikar Ali Bhutto | Director | 30 Dec 2020 | 5 Years 9 Months | Current |
| Zahangir Alom | Director | 29 Jul 2020 | 6 Years 2 Months | Current |
Charges & Borrowings of Gariox Pharmaceuticals Private Limited
Gariox Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Gariox Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Gariox Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Gariox Pharmaceuticals Private Limited
Gariox Pharmaceuticals Private Limited has 6 board changes on record since 2020: 3 appointments and 3 cessations. The latest: Abdul Kadir ceased to be Additional Director on 28 Aug 2023.
Credit Ratings, Litigation & Regulatory Alerts for Gariox Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Gariox Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Gariox Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Gariox Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Gariox Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gariox Pharmaceuticals Private Limited
Gariox Pharmaceuticals is an active private limited company based in Bhiwandi, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 29 July 2020 (6+ years old) and is registered under CIN U24230MH2020PTC342897.
Gariox Pharmaceuticals reported revenue of ₹2.45 Lakh for FY 2022 (up 2347% YoY).
Gariox Pharmaceuticals has 3 current directors:
- Aktara Begum - Additional Director
- Julfikar Ali Bhutto - Director
- Zahangir Alom - Director
Gariox Pharmaceuticals reported a net loss of ₹63,090 (net margin -25.8%) and EBITDA of -₹62,866 (EBITDA margin -25.7%) for FY 2022, as per its filed financial statements.
The CIN (Corporate Identification Number) of Gariox Pharmaceuticals is U24230MH2020PTC342897. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gariox Pharmaceuticals was incorporated on 29 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Gariox Pharmaceuticals by revenue are Lucenta Pharmaceuticals Private Limited, Cemach Pharmaceuticals Private Limited, Medesign Pharmaceuticals Private Limited, Morbocure Pharmaceuticals Private Limited, Qassur Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Abdul Kadir ceased to be Additional Director on 28 Aug 2023. Aktara Begum was appointed as Additional Director on 08 Jun 2022. Julfikar Ali Bhutto ceased to be Additional Director on 31 Dec 2021. Gariox Pharmaceuticals has 6 board changes on record in total.
The registered office of Gariox Pharmaceuticals is at H.No. 1000 Salman Nagar Mahapoli Village Wada Rd Bhiwandi, Maharashtra, India – 421302.
Gariox Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Gariox Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.